The PennZone

  • Home
  • Health
  • Business
  • Non-profit
  • Music
  • Construction
  • Sports
  • Technology
  • Books

Velocity Data Announces Agreement to Acquire NuBreed Nutrition Inc
The PennZone/10077645

Trending...
  • Neurosurgeon Chengyuan Wu, MD, MSBmE, Joins the Actuated Medical Advisory Board
  • OneSolution® Expands to Orlando with New Altamonte Springs Implant Center
  • Appliance EMT Expands Professional Appliance Repair Services to Hartford, Connecticut
Emergence Global Enterprises Inc.
Not For Distribution To Press Services In The United States And Not For Circulation In The United States

WINDSOR, Ontario - PennZone -- Velocity Data (now know as Emergence Global Enterprises Inc., but listed for trading on the Canadian Securities Exchange as Velocity Data Inc.) is pleased to announce that it has entered into a binding share purchase agreement (the "Purchase Agreement"), dated July 31, 2020, pursuant to which the Company has agreed to acquire all of the issued and outstanding shares in the capital of Nubreed Nutrition, Inc. ("Nubreed") (the "Transaction"), a developer and distributor of branded sports and nutrition specialty supplements. In connection with the Purchase Agreement, the sole shareholder of Nubreed (the "Vendor") is entitled to receive aggregate consideration of 1,000,000 common shares in the capital of the Company ("Common Shares") to be issued to the Vendor at the closing time.

The Transaction is expected to result in a "Change of Business" of the Company as such term is defined in Canadian Securities Exchange Policy No. 8 – "Fundamental Changes & Changes of Business". Once consummated, the Transaction will change the nature of the Issuer's business from being a distributor of computer systems and related components to a builder of reputable consumer brands using leading innovation, integrated platforms and full traceability for the health food marketplace. The completion of the Transaction is subject to certain conditions precedent including receipt of approval from the Canadian Securities Exchange.

More on The PennZone
  • Mitchell Sipus Releases New Dance Single "Can U"
  • FrostSkin Launches Kickstarter Campaign for Patent-Pending Instant-Chill Water Purification Bottle
  • The New Monaco of the South (of Italy)
  • OctoNerv Completes Functional Prototype of Electronic Breast Nipple Implant (EBNI)
  • Zivra AI Launches Real-Time Business Health and Financial Intelligence for SMEs

About the Company (listed on the Canadian Securities Exchange as "Velocity Data Inc.")

The Company is in a transition phase. On February 28, 2018, the Company announced its intention to exit its business of selling computer systems and related components and focus on new investments and projects. The Company's business was previously conducted by the Company's wholly owned subsidiary ACL Computers and Software Inc.. On January 28, 2020, the CSE notified the Company that it did not meet the continued listing requirements as set out in CSE Policy 2, Appendix A, Section 2.9 and the CSE considered the Company "inactive". In accordance with CSE Policy 3, Section 5.1, an ".X" extension was added to the Company's trading symbol. The Company is considering a number of development projects, including by way of strategic acquisition, including the proposed Transaction.

Additional information about the Company can be found on SEDAR at www.sedar.com under the Issuer Profile of "Velocity Data Inc.".

About Nubreed Nutrition, Inc.

Nubreed is a private corporation organized under the laws of the State of Michigan. It develops and distributes branded sports and nutrition specialty supplements in the United States, Canada, Australia and other jurisdictions.

Cautionary Statement Regarding Forward-Looking Information

F
orward-Looking Statements

This news release includes certain "forward-looking statements" under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to: closing and the terms and conditions of the proposed transaction; the business and operations of the Company after closing the proposed transaction. Forward looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; delay or failure to receive board, shareholder or regulatory approvals; and the uncertainties surrounding the nutraceutical and botanical industry. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. There can be no assurance that the proposed transaction will occur or that the anticipated financial, economic or strategic benefits will be realized.  The completion of the proposed transaction is subject to a number of conditions including approval of the Canadian Securities Exchange, and there can be no assurance that approvals will be obtained and/or any other conditions will be met.

More on The PennZone
  • Obey God Clothing Launches Urban Christian Apparel Line Serving All Ages
  • PA Golf Cart World Launches NEV Pre-Inspection & Compliance Service for 2026
  • Dr. Curtis Rasmussen Shares Leadership and AI Insights on Lead Empowered TV
  • Lick Personal Oils Introduces the Ultimate Valentine's Day Gift Collection for Romantic, Thoughtful Gifting
  • Lacy Hendricks Earns Prestigious MPM® Designation from NARPM®

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this press release.

Media Contact
Emergence Global Inc. / Velocity Data
Joe Byrne, President and CEO
ir@emergenceglobalinc.com


Source: Velocity Data / Emergence Global Enterprises
Filed Under: Health

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Golden Paper Launches a New Chapter in Its Americas Strategy- EXPOPRINT Latin America 2026 in Brazil
  • UK Financial Ltd Executes Compliance Tasks Ahead Of First-Ever ERC-3643 Exchange-Traded Token, SMCAT & Sets Date For Online Investor Governance Vote
  • TheOneLofi2: New Home for Chill Lo-Fi Hip Hop Beats Launches on YouTube
  • eJoule Inc Participates in Silicon Dragon CES 2026
  • HBZBZL Unveils "Intelligent Ecosystem" Strategy: Integrating AI Analytics with Web3 Incubation
  • Kaltra Launches Next-Gen MCHEdesign With Full Integration Into MCHEselect — Instant Simulation & Seamless Microchannel Coil Workflow
  • A Well-Fed World, Youth Climate Save and PAN International Launch PHRESH: A Global Directory of Plant-Based Hunger Relief Organizations
  • Guests Can Save 25 Percent Off Last Minute Bookings at KeysCaribbean's Village at Hawks Cay Villas
  • Trump's Executive Order Rescheduling Cannabis: Accelerating M&A in a Multibillion-Dollar Industry
  • Genuine Hospitality, LLC Selected to Operate Hilton Garden Inn Birmingham SE / Liberty Park
  • Together We Dance Foundation Announces Transformational Support from NAC Have a Heart Foundation
  • Harry Hayman Celebrates Years of WHYY Coverage, Partnership & Shared Commitment to Philadelphia
  • Documentary "Prescription for Violence: Psychiatry's Deadly Side Effects" Premieres, Exposes Link Between Psychiatric Drugs and Acts of Mass Violence
  • Stockwell Elastomerics expands micro molding capabilities
  • Price Improvement on Luxurious Lāna'i Townhome with Stunning Ocean Views
  • Nextvisit Co-Founder Ryan Yannelli Identifies Six Critical Factors for Behavioral Health Providers Evaluating AI Scribes in 2026
  • Healthcare Executive Derek Streich Launches Professional Website with Derek Streich Video Biography
  • CredHub and Real Property Management Join Forces to Empower Franchise Owners with Rental Payment Credit Reporting Solutions
  • Leimert Park Announces Weeklong Kwanzaa Festival & Kwanzaa Parade Celebrating Black History, Culture, and Community
  • Schmuck Lumber Ace Hardware Opens New Greenhouse Addition

Popular on PennZone

  • UK Financial Ltd Board of Directors Establishes Official News Distribution Framework and Issues Governance Decision on Official Telegram Channels - 206
  • Phinge CEO Ranked #1 Globally by Crunchbase for the Last Week, Will Be in Las Vegas Jan. 4-9, the Week of CES to Discuss Netverse & IPO Coming in 2026 - 188
  • Neurosurgeon Chengyuan Wu, MD, MSBmE, Joins the Actuated Medical Advisory Board
  • Twin Flame Visions Disrupts the Industry With Record Ad Performance and Rapid User Growth
  • SIMM Capital Fund Surpasses $25M Raised and $100M+ in Real Estate Assets
  • Children Rising Appoints Marshelle A. Wilburn as New Executive Director
  • NAFMNP Awarded USDA Cooperative Agreement to Continue MarketLink Program Under FFAB
  • Harry Hayman of Feed Philly Coalition Proudly Supports Sharing Excess' Holiday Food Rescue — Bri
  • Bent Danholm Joins The American Dream TV as Central Florida Host
  • God's Meal Barrel Combats the Increased Community Need in 2025

Similar on PennZone

  • Anne Seidman: Within the Lines
  • How Democrats Made Healthcare More Expensive in 2026
  • FrostSkin Launches Kickstarter Campaign for Patent-Pending Instant-Chill Water Purification Bottle
  • Obey God Clothing Launches Urban Christian Apparel Line Serving All Ages
  • Lick Personal Oils Introduces the Ultimate Valentine's Day Gift Collection for Romantic, Thoughtful Gifting
  • Walmart $WMT and COSTCO.COM $COST Distribution as SonicShieldX™ Platform Sets the Stage for Accelerated Growth in 2026: AXIL Brands (N Y S E: AXIL)
  • AI-Driven Drug Development with Publication of New Bioinformatics Whitepaper for BullFrog AI: $BFRG Strengthens Its Position in AI Drug Development
  • Java Holdings LLC Acquires +Peptide, Expanding Portfolio Across Coffee, Science, and Functional Nutrition
  • OneSolution® Expands to Orlando with New Altamonte Springs Implant Center
  • Robert DeMaio, Phinge Founder & CEO, Ranked #1 Globally on Crunchbase, Continues to Convert Previous Debt Owed to Him by Phinge into Convertible Notes
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us